Kanata Sohya, Akagi Masao, Nishimura Shunji, Hayakawa Sumio, Yoshida Kohji, Sawamura Tatsuya, Munakata Hiroshi, Hamanishi Chiaki
Department of Orthopaedic Surgery, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama City, Osaka, 589-8511, Japan.
Biochem Biophys Res Commun. 2006 Sep 29;348(3):1003-10. doi: 10.1016/j.bbrc.2006.07.133. Epub 2006 Jul 31.
It has been reported that vascular endothelial growth factor (VEGF) and its receptors play an important role in the destruction of articular cartilage in osteoarthritis through increased production of matrix metalloproteinases. We investigated whether the oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) upregulates VEGF expression in cultured bovine articular chondrocytes (BACs). Ox-LDL markedly increased VEGF mRNA expression and protein release in time- and dose-dependent manners, which was significantly suppressed by anti-LOX-1 antibody pretreatment. Activation of peroxisome proliferator-activated receptor (PPAR)-gamma was evident in BACs with ox-LDL addition and was attenuated by anti-LOX-1 antibody. The specific PPAR-gamma inhibitor GW9662 suppressed ox-LDL-induced VEGF expression. These results suggest that the ox-LDL/LOX-1 system upregulates VEGF expression in articular cartilage, at least in part, through activation of PPAR-gamma and supports the hypothesis that ox-LDL is involved in cartilage degradation via LOX-1.
据报道,血管内皮生长因子(VEGF)及其受体通过增加基质金属蛋白酶的产生,在骨关节炎关节软骨破坏中起重要作用。我们研究了氧化型低密度脂蛋白(ox-LDL)与凝集素样氧化型低密度脂蛋白受体-1(LOX-1)结合是否会上调培养的牛关节软骨细胞(BACs)中VEGF的表达。氧化型低密度脂蛋白以时间和剂量依赖性方式显著增加VEGF mRNA表达和蛋白质释放,抗LOX-1抗体预处理可显著抑制这种增加。添加氧化型低密度脂蛋白的BACs中过氧化物酶体增殖物激活受体(PPAR)-γ明显被激活,抗LOX-1抗体可使其减弱。特异性PPAR-γ抑制剂GW9662可抑制氧化型低密度脂蛋白诱导的VEGF表达。这些结果表明,氧化型低密度脂蛋白/LOX-1系统至少部分通过激活PPAR-γ上调关节软骨中VEGF的表达,并支持氧化型低密度脂蛋白通过LOX-1参与软骨降解的假说。